ProMIS Neurosciences Inc. (PMN)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

9.61 on 9 Oct 2026

8 buys0 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$39.72M

Free cash flow

$28.12M

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
5 Aug 2026	Kaplan Johanne Chief Development Officer	Bought	$30.32K	57.9%
22 Apr 2026	Kirwin Patrick D. Director	Bought	$45.32K	613%
5 Mar 2026	Williams Eugene Director	Bought	$48.80K	19.2%
4 Mar 2026	Williams Eugene Director	Bought	$48.00K	23.8%
3 Mar 2026	Williams Eugene Director	Bought	$21.89K	13.5%
2 Mar 2026	Williams Eugene Director	Bought	$22.53K	15.6%

53out of 100

Profitability 20

Financial strength 55

Growth n/a

Insiders 100

Strongest on insiders (100), weakest on profitability (20). A score of the business, not of the price.

Last 12 months

Only here

Bought

$8.74M

8 buys, 4 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan